Skip to main content
logo
CRISM Therapeutics Corporation (AIM:CRTX)
London flag London · Delayed Price · Currency is GBP · Price in GBX
9.18
-0.33 (-3.42%)
Jul 24, 2026, 4:15 PM GMT

CRISM Therapeutics Financials Overview

Millions GBP. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
0.230.230.030.05--
Revenue Growth
824.00%824.00%-44.44%---
Gross Profit
0.130.130.020.01--
Operating Income
-1.88-1.88-0.88-0.17-1.85-1.32
Net Income
-1.9-1.9-0.61-0.2-2.5-0.89
Earnings Per Share
-0.05-0.05-0.02-12.25-0.29-0.10
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
1.131.131.2802.894.93
Total Debt
---0.7--
Net Cash (Debt)
1.131.131.28-0.72.894.93
Net Cash Growth
223.21%-12.01%---41.42%141.49%
Net Cash Per Share
0.030.030.04-43.500.330.57

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-1.97-1.97-0.93-0.1-2.92-1.35
Capital Expenditures
------0.31
Free Cash Flow
-1.97-1.97-0.93-0.1-2.92-1.67
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
56.71%56.71%84.00%28.89%--
Operating Margin
-812.99%-812.99%-3520.00%-377.78%--
Pretax Margin
-812.99%-812.99%-2372.00%-448.89%--
Profit Margin
-823.81%-823.81%-2428.00%-435.56%--
FCF Margin
-851.51%-851.51%-3732.00%-217.78%--

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
22.3022.40143.7827.86--